Related Experiment Video

Updated: May 19, 2026

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
15:04

Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation

Published on: January 19, 2019

Ion interference and its combined therapies for cancer treatments

Xinkai Hu1,2, Dongdong Guo1,2, Nguyen Thi Kim Thanh1,2

  • 1Biophysics Group, Department of Physics and Astronomy, University College London, Gower Street, London WC1E 6BT, UK. ntk.thanh@ucl.ac.uk.

Nanoscale
|May 18, 2026
PubMed

Insights

Nano-engineered platforms enable ion interference therapy to selectively target cancer cells by disrupting ionic homeostasis. This precision nanomedicine approach offers adaptable, effective tumour-specific treatments with reduced toxicity.

Area of Science:

  • Oncology
  • Nanomedicine
  • Biomedical Engineering

Background:

  • Current cancer therapies require improvement for tumour specificity and reduced systemic toxicity.
  • Intracellular ion homeostasis is crucial for cancer cell survival.
  • Ion interference therapy offers a novel strategy to exploit ionic imbalances for cancer treatment.

Purpose of the Study:

  • To explore nano-engineered platforms for ion interference therapy.
  • To investigate the potential of manipulating ion fluxes for targeted cancer treatment.
  • To highlight the advantages of stimulus-responsive, spatially confined cytotoxicity.

Main Methods:

  • Development of nano-engineered platforms for ion flux manipulation.
  • Utilizing ion-releasing nanomaterials and artificial nanochannels.
  • Integration with conventional therapeutic modalities.

Main Results:

  • Nano-engineered platforms enable precise control over ion fluxes.
  • Demonstrated selective disruption of tumour viability through ion interference.
  • Achieved stimulus-responsive and spatially confined cytotoxicity.

Conclusions:

  • Nano-enabled ion interference therapy is a promising strategy for precision nanomedicine.
  • This approach offers adaptable, tumour-specific treatments with high efficacy and low toxicity.
  • Further development holds potential for advanced oncology treatments.

More Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma06:15

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on: October 27, 2014

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...